Pulse Biosciences Inc Stock
€21.60
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Pulse
sharewise wants to provide you with the best news and tools for Pulse, so we directly link to the best financial data sources.
Financials
News
Pulse Biosciences Q1 Earnings Call Highlights
Pulse Biosciences (NASDAQ:PLSE) said it is sharpening its focus on its nanosecond pulsed field ablation platform for atrial fibrillation after reporting first-quarter 2026 results and highlighting
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
On May 11, 2026, Paul A. LaViolette, Chief Executive Officer of Pulse Biosciences (NASDAQ:PLSE), a developer of non-thermal bioelectric treatments, reported the direct purchase of 15,000 shares of


